| (Values in U.S. Thousands) | Aug, 2026 | Aug, 2026 | Aug, 2026 | Aug, 2026 | Aug, 2026 |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | 0 | 0 | 0 | 0 | 0 |
| Net Income Growth | unch | unch | unch | unch | unch |
Sysmex Corp (SSMXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Sysmex Corporation was incorporated on February 20, 1968 and is headquartered in Japan. The company is engaged in manufacturing of clinical testing devices, and is involved in R&D, production, marketing, servicing and support of instruments, reagents and software for hematology, urinalysis and immunochemistry, and provides total solutions to its customers. The company provides various diagnostic products in the hematology, hemostasis, urinalysis, chemistry and life science fields. Its competitors are based outside of Japan. In Japan, it has three competitor groups, namely, reagent specialist manufacturers, instrument specialist manufacturers, and reagent and instrument manufacturers.